Something is changing in the diagnosis and treatment of non-muscle invasive bladder cancers (NMIBC).
作者信息
Sousa Escandón Alejandro
机构信息
Servicio de Urología. Hospital Comarcal de Monforte. Lugo. España.
出版信息
Arch Esp Urol. 2018 May;71(4):325-327.
PMID:29745920
Abstract
摘要
相似文献
1
Something is changing in the diagnosis and treatment of non-muscle invasive bladder cancers (NMIBC).
Arch Esp Urol. 2018 May;71(4):325-327.
2
Optimal risk-adapted surveillance strategies for NMIBC, including upper tract imaging.
Urol Clin North Am. 2013 May;40(2):305-15. doi: 10.1016/j.ucl.2013.01.013. Epub 2013 Feb 19.
3
Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future.
World J Urol. 2019 Oct;37(10):1999-2000. doi: 10.1007/s00345-019-02894-5.
4
[Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art].
Aktuelle Urol. 2010 Sep;41(5):307-15. doi: 10.1055/s-0030-1262555. Epub 2010 Sep 7.
5
Role and rationale of gene therapy and other novel therapies in the management of NMIBC.
Expert Rev Anticancer Ther. 2009 Dec;9(12):1777-82. doi: 10.1586/era.09.106.
6
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.
Eur Urol. 2013 Jan;63(1):36-44. doi: 10.1016/j.eururo.2012.08.061. Epub 2012 Sep 5.
7
Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinoma.
Hematol Oncol Clin North Am. 2015 Apr;29(2):219-25, vii. doi: 10.1016/j.hoc.2014.11.001.
8
[Management of non invasive bladder tumours (NMIBC)].
Bull Cancer. 2010;97 Suppl Cancer de la vessie:11-7. doi: 10.1684/bdc.2010.1105.
9
Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
J Exp Clin Cancer Res. 2014 Aug 22;33(1):68. doi: 10.1186/s13046-014-0068-7.
10
Diagnosis of Bladder Carcinoma: A Clinician's Perspective.
Surg Pathol Clin. 2015 Dec;8(4):677-85. doi: 10.1016/j.path.2015.07.004.
Zotero 插件